SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-019051
Filing Date
2022-07-12
Accepted
2022-07-12 09:16:25
Documents
15
Period of Report
2022-07-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45655
2 ex1-1.htm EX-1.1 267844
3 ex5-1.htm EX-5.1 12652
4 ex5-1_001.jpg GRAPHIC 2584
  Complete submission text file 0001493152-22-019051.txt   570788

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT glsi-20220712.xsd EX-101.SCH 2998
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT glsi-20220712_lab.xml EX-101.LAB 34916
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT glsi-20220712_pre.xml EX-101.PRE 22815
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3876
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39555 | Film No.: 221078335
SIC: 2834 Pharmaceutical Preparations